Tilray Brands Stock (NASDAQ:TLRY)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$5.02

52W Range

$3.50 - $23.20

50D Avg

$5.97

200D Avg

$9.36

Market Cap

$612.37M

Avg Vol (3M)

$4.65M

Beta

1.88

Div Yield

-

TLRY Company Profile


Tilray Brands, Inc. is a diversified global consumer packaged goods company primarily involved in the cultivation, processing, marketing, and sale of cannabis products. Its operations span a significant international footprint, encompassing Canada, the United States, Europe, Australia, New Zealand, and Latin America. The company organizes its business across four distinct divisions: Cannabis, Distribution, Beverage Alcohol, and Wellness. Within its cannabis division, Tilray provides a comprehensive range of medical and adult-use items, including regulated products like GMP-certified cannabis flowers, oils, vaporizers, edibles, and topical applications. Beyond cannabis, Tilray's portfolio extends to the procurement and resale of pharmaceutical and wellness goods. Furthermore, it manufactures, promotes, and distributes a variety of alcoholic beverages, alongside hemp-derived food and other wellness items. The company markets its diverse offerings under numerous recognized brands, such as Tilray, Aphria, SweetWater, and Breckenridge Distillery. Its products reach a wide array of customers, including retail outlets, wholesale partners, medical patients, healthcare practitioners, hospitals, pharmacies, scientific researchers, governmental bodies, and directly to end consumers. Formerly operating as Tilray, Inc., the corporation is headquartered in Leamington, Canada.

Show More

Industry

Drug Manufacturers - Specialty & Generic

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

CA

Employees

2,650

IPO Date

Jul 19, 2018

Website

TLRY Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceMay 25May 24May 23
Wellness Business$60.48M$55.31M-
Cannabis Segment$330.61M$370.69M-
Distribution Revenue$271.23M$258.74M-
Beverage Alcohol Business$253.18M$213.61M$100.68M

Fiscal year ends in May 25 | Currency in USD

TLRY Financial Summary


May 25May 24May 23
Revenue$821.31M$788.94M$627.12M
Operating Income$-1.70B$-174.75M$-1.37B
Net Income$-2.18B$-244.98M$-1.44B
EBITDA$-1.70B$-72.84M$-889.52M
Basic EPS$-2.46$-0.33$-2.34
Diluted EPS$-2.46$-0.33$-2.34

Fiscal year ends in May 25 | Currency in USD

Latest Earnings Call Transcripts


Q3 26Apr 01, 26 | 8:30 AM
Q2 26Jan 08, 26 | 12:00 AM
Q1 26Oct 09, 25 | 8:30 AM

Peer Comparison


TickerCompany
MAZEMaze Therapeutics, Inc.
AMPHAmphastar Pharmaceuticals, Inc.
EVOEvotec SE
HROWHarrow Health, Inc.
NEOGNeogen Corporation
DVAXDynavax Technologies Corporation
NTLAIntellia Therapeutics, Inc.
PAHCPhibro Animal Health Corporation
ALVOAlvotech
IMNMImmunome, Inc.